SCHEMBL25856484

SCHEMBL25856484

CC1CCN(CC2CCN(C3CCC(N)CC3)CC2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.53
POLB P06746 3/20 0.36
KDM4E B2RXH2 2/20 0.36
THRB P10828 2/20 0.34
CARM1 Q86X55 1/20 0.33
PRMT6 Q96LA8 1/20 0.33
PRMT1 Q99873 1/20 0.33
PRMT8 Q9NR22 1/20 0.33
CHRM5 P08912 1/20 0.33
ADRA2C P18825 1/20 0.33
LMNA P02545 1/20 0.33
EBP Q15125 2/20 0.33
DHCR7 Q9UBM7 2/20 0.33
HRH3 Q9Y5N1 2/20 0.33
ALDH1A1 P00352 1/20 0.33
ALOX15 P16050 1/20 0.33
HTT P42858 1/20 0.32
OPRM1 P35372 1/20 0.32
OPRK1 P41145 1/20 0.32
OPRL1 P41146 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24480750 0.87 ACHE (0.49) ACHEPOLBCARM1PRMT6PRMT1
SCHEMBL13247999 0.84 ACHE (0.62) ACHEPOLBKDM4ETHRBCARM1
SCHEMBL156650 0.84 KDM4E (0.41) ACHEPOLBKDM4ECARM1PRMT6
SCHEMBL25856195 0.83 CHRM5 (0.53) ACHEKDM4ETHRBCHRM5ADRA2C
SCHEMBL13247682 0.80 CHRM5 (0.39) ACHEPOLBKDM4ECHRM5ADRA2C
SCHEMBL842660 0.80 CHRM5 (0.39) ACHEKDM4ECHRM5ADRA2COPRM1
SCHEMBL372638 0.80 CHRM5 (0.39) ACHEKDM4ECHRM5ADRA2COPRM1
SCHEMBL372637 0.80 CHRM5 (0.39) ACHEKDM4ECHRM5ADRA2COPRM1
Hydrochloric Acid SCHEMBL19002912 0.79 CHRM5 (0.38) ACHEKDM4ECHRM5ADRA2COPRM1
Hydrochloric Acid SCHEMBL19002911 0.79 CHRM5 (0.38) ACHEKDM4ECHRM5ADRA2COPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397661-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-07-10 EP disclosed
WO-2023131167-A1 COMPOUND FOR INHIBITING AND DEGRADING IRAK4, AND PHARMACEUTICAL COMPOSITION AND PHARMACEUTICAL APPLICATION THEREOF 海思科医药集团股份有限公司 2023-07-13 WO disclosed